United States & United States — Medicare
25 shared events · Importance 4 · Last updated Aug 20, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States: The United States government, through the Trump administration, is attempting to reduce healthcare costs for its citizens, particularly United States — Medicare patients.
United States — Medicare: United States — Medicare is the federal health insurance program whose patients are expected to save $1.1 billion annually due to the proposed rule, specifically those with United States — Medicare Part B coverage.
Jul 02, 2026 · 9 articles
Domestic
United States: The country's drug prices are declining, benefiting consumers but potentially affecting pharmaceutical industry revenues.
United States — Medicare: United States — Medicare's new negotiation powers under the IRA are a key driver of lower drug prices.
Aug 18, 2026 · 9 articles
Domestic
United States: The U.S. government was the victim of the fraud and facilitated the arrest through international cooperation.
United States — Medicare: Medicare was the victim of the alleged fraud, losing over half a billion dollars; the case highlights program vulnerabilities.
Jul 21, 2026 · 20 articles
Business
United States: The United States is another target market for LifeFit Group's expansion, representing a significant opportunity for growth.
United States — Medicare: United States — Medicare, the developer of LifeFit Group, leverages its healthcare expertise to enter the digital health space, potentially enhancing its brand and customer base.
Aug 11, 2026 · 8 articles
Business
United States: The United States is the primary market for Walmart, and its regulatory actions on United States — Medicare drug pricing negatively impacted Walmart's pharmacy sales. Weak retail sales data and consumer pessimism in the U.S. contribute to the challenging environment.
United States — Medicare: United States — Medicare regulations requiring capped prices on high-cost drugs reduced Walmart's pharmacy sales, contributing to the slower comparable sales growth. This regulatory impact is a key factor in the quarter's results.
Aug 20, 2026 · 7 articles
Domestic
United States: The United States>>> annually authorizes millions of dollars to support United States — United States Department of Veterans Affairs>>> clinicians in Veterans Treatment Courts and created a new center for this goal, but funding cuts still pose challenges.
United States — Medicare: Cuts to United States — Medicare>>>, a publicly funded healthcare program, are making it harder for veterans to access necessary healthcare services, impacting Veterans Treatment Courts.
May 19, 2026 · 6 articles
Tech
United States: The study was conducted in 27 sites across the United States, and its findings have significant implications for public health and healthcare spending within the nation.
United States — Medicare: Participants in the study were enrolled in United States — Medicare, and their claims data were linked, demonstrating the relevance of the study to public health insurance programs.
Jun 15, 2026 · 6 articles
Regulatory
United States: As the jurisdiction, the US legal system enforced anti-kickback laws, recovering funds and deterring future fraud.
United States — Medicare: Taxpayer-funded program affected by fraudulent billing; the scheme undermined its integrity and safeguards.
Aug 11, 2026 · 6 articles
Regulatory
United States: The United States passed new PBM regulations in February, preventing PBMs from keeping rebates negotiated on drug prices for health plans supplementing federal United States — Medicare coverage. This indicates a federal-level intervention in PBM regulation.
United States — Medicare: United States — Medicare is affected by new federal regulations that prevent PBMs from keeping rebates on drug prices for health plans that supplement its coverage, aiming to lower costs for beneficiaries.
Jun 27, 2026 · 6 articles
Business
United States: The United States is the target market for Grey Matters Health Inc.'s expansion of neuroimaging clinics, addressing a growing demand for Alzheimer's detection and treatment within the country.
United States — Medicare: United States — Medicare covers brain PET scans for beta-amyloid plaque detection and new monoclonal antibody treatments for Alzheimer's Disease, which is crucial for patient access to Grey Matters Health Inc.'s services.
Jul 06, 2026 · 6 articles
Regulatory
United States — Medicare: United States — Medicare will expand coverage for obesity drugs starting next year, including for people with severe obesity or those overweight/obese with serious health problems, with qualifying patients paying $50 copays.
Nov 06, 2025 · 6 articles
Domestic
United States — Medicare: United States — Medicare Part B premiums are projected to increase, which will offset a significant portion of the Social Security COLA increase for retirees.
Sep 08, 2025 · 20 articles
general
Mar 03, 2026 · 96 articles
Tech
United States — Medicare: Patients on United States — Medicare were more likely to discontinue GLP-1 medications, suggesting a demographic factor influencing adherence.
Jun 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and United States — Medicare interact across events, view sentiment trends, and discover connected entities.
Open Dashboard